BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16447138)

  • 1. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005.
    Klein JO; Helms CM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138
    [No Abstract]   [Full Text] [Related]  

  • 2. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.
    Klein JO; Myers MG
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
    Tan L;
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
    Pisano W
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
    Evans G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wyeth responds to criticism.
    Stiles GM
    Md Med; 2005; 6(4):5, 7-8; author reply 8. PubMed ID: 16454430
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
    Rodewald LE; Orenstein WA; Mason DD; Cochi SL
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing childhood vaccines.
    Davis MM; Kemper AR
    J Pediatr; 2003 Sep; 143(3):283-4. PubMed ID: 14517503
    [No Abstract]   [Full Text] [Related]  

  • 9. The fragility of the U.S. vaccine supply.
    Sloan FA; Berman S; Rosenbaum S; Chalk RA; Giffin RB
    N Engl J Med; 2004 Dec; 351(23):2443-7. PubMed ID: 15575064
    [No Abstract]   [Full Text] [Related]  

  • 10. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee.
    Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B;
    JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wyeth Pharmaceutical's perspective on vaccine production.
    Stiles GL
    Md Med; 2005; 6(1):22-3. PubMed ID: 15869103
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing vaccine-preventable diseases in low-resource communities.
    Rodewald LE; Markowitz LE
    Arch Pediatr Adolesc Med; 2009 May; 163(5):487-8. PubMed ID: 19414699
    [No Abstract]   [Full Text] [Related]  

  • 13. A response to strategy #2: streamlining the regulatory process.
    Glezen WP
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S141-4. PubMed ID: 16447137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed consent and public health: are they compatible when it comes to vaccines?
    Parmet WE
    J Health Care Law Policy; 2005; 8(1):71-110. PubMed ID: 16538802
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 16. Compensation for vaccine injury: balancing society's need and personal risk.
    Grabenstein JD
    Hosp Pharm; 1995 Sep; 30(9):831-2, 834-6. PubMed ID: 10151285
    [No Abstract]   [Full Text] [Related]  

  • 17. Valuing childhood vaccines.
    Schlenker T
    J Pediatr; 2004 Oct; 145(4):568; author reply 568. PubMed ID: 15480391
    [No Abstract]   [Full Text] [Related]  

  • 18. The vaccine crossroads.
    Wilson JF
    Ann Intern Med; 2003 May; 138(10):857-60. PubMed ID: 12755580
    [No Abstract]   [Full Text] [Related]  

  • 19. The U.S. vaccine supply.
    Schwartz HK
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15762001
    [No Abstract]   [Full Text] [Related]  

  • 20. Markets and public health: pushing and pulling vaccines into production.
    Wynia MK
    Am J Bioeth; 2006; 6(3):3-6. PubMed ID: 16754439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.